Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01869777 · ADVERSE EVENTS

Adverse events

Bioelectrical Impedance Measurement for Predicting Treatment Outcome in Patients With Newly Diagnosed Acute Leukemia · Source last updated 2020-08-13

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.

Collection time frame
Up to 2 years to assess for survival only
Other-event reporting threshold
0%

Adverse events were not monitored/assessed for this trial.

Participants affected / participants at risk, as reported
Safety groupSerious eventsOther eventsDeaths
Diagnostic (Bioelectric Impedance Analysis)

Patients undergo bioelectrical impedance phase angle measurement on day 1 of treatment. Patients with AML undergo a second measurement just prior to the nadir marrow. Patients also undergo bioelectrical impedance measurements prior to any invasive procedures (bone marrow biopsy, leukapheresis, PICC line placement, etc.). bioelectric impedance analysis: Undergo bioelectric impedance analysis

0 / 00 / 016 / 101

Group identifiers: EG000: Diagnostic (Bioelectric Impedance Analysis)

Serious adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

    Other reported adverse events

    Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

      Complete source fields
      description
      Adverse events were not monitored/assessed for this trial.
      event Groups
      1. deaths Num Affected
        16
        deaths Num At Risk
        101
        description
        Patients undergo bioelectrical impedance phase angle measurement on day 1 of treatment. Patients with AML undergo a second measurement just prior to the nadir marrow. Patients also undergo bioelectrical impedance measurements prior to any invasive procedures (bone marrow biopsy, leukapheresis, PICC line placement, etc.). bioelectric impedance analysis: Undergo bioelectric impedance analysis
        id
        EG000
        other Num Affected
        0
        other Num At Risk
        0
        serious Num Affected
        0
        serious Num At Risk
        0
        title
        Diagnostic (Bioelectric Impedance Analysis)
      frequency Threshold
      0
      time Frame
      Up to 2 years to assess for survival only

      Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

      Preserved source evidence · Not medical advice